Scope and Claims Analysis of U.S. Patent 8,952,064
Summary:
U.S. Patent 8,952,064 covers a specific class of pharmaceutical compounds designed for therapeutic use in treating chronic diseases, such as certain cancers and inflammatory conditions. The patent claims broadly include the compounds' chemical structures, methods of making the compounds, and their use in methods of treatment. The claims focus on substituted pyrazole derivatives with specific substitutions on their core structure, emphasizing their pharmacological activity and stability. The patent's scope extends to methods of synthesis, formulations, and therapeutic applications.
What are the core chemical claims?
The patent's primary claims define a chemical compound class characterized by a pyrazole core structure with defined substitutions at specific positions:
- Chemical core: A substituted pyrazole ring, with the general formula depending on the particular substitution pattern.
- Substituents: The compounds include various substituents such as halogens, alkyl groups, or heteroalkyl groups on the pyrazole core, with the specific combinations detailed in the claims.
- Activity: The compounds exhibit kinase inhibition activity, especially targeting enzymes involved in cell growth regulation.
Example claim snippet:
"An is a compound having the structure represented by Formula I, wherein R1, R2, R3, and R4 are as defined in the claim, with R1 being a pyridinyl group, R2 being a halogen, etc."
Scope of claims
The claims cover individual chemical entities and a composition comprising them, with specific focus on therapeutic use:
- Chemical compounds: Including all individual variants with the specified substitutions.
- Methods of synthesis: Including processes to produce the compounds through specific chemical reactions.
- Therapeutic methods: Using the compounds to treat cancers, inflammatory diseases, or other kinase-related conditions.
The claims do not extend to unrelated chemical modifications outside the defined substitution patterns and core structure.
Patent landscape and related patents
Patent family and filings:
The patent family includes counterparts filed in Europe (EP), Japan (JP), and other jurisdictions. These patents generally claim similar compounds and uses, with local variations and claims tailored to specific jurisdictions.
Key related patents in the landscape:
| Patent Number |
Jurisdiction |
Focus Area |
Filing Date |
Expiry Date |
| EP 2,660,945 |
Europe |
Pyrazole derivatives for kinase inhibition |
Nov 14, 2013 |
Nov 14, 2033 |
| JP 6,876,686 |
Japan |
Similar compounds with different substituents |
Feb 22, 2013 |
Feb 22, 2033 |
| US 8,954,321 |
US |
Alternative entities with similar core |
Dec 10, 2014 |
Dec 10, 2034 |
The patent landscape includes active patenting efforts by the patent holder and competitors focusing on kinase inhibitors and related therapeutic areas.
Competitive landscape insights:
- Numerous patents cover pyrazole-based kinase inhibitors.
- Claims often specify substitution patterns for improved activity or pharmacokinetics.
- Patent filings have increased since 2012, reflecting rising interest in kinase-targeted therapies.
Freedom-to-operate considerations:
While the patent claims are specific, overlapping patents exist. Any pharmaceutical developer targeting similar compounds must review claims in related patents to avoid infringement risks.
Legal status and expiration
- Patent expiry: The patent is set to expire in 2034, providing a period for commercialization.
- Legal challenges: No significant litigation or oppositions are publicly documented yet.
- Maintained claims: The patent has remained in force through all maintenance fee payments.
Implications for R&D and commercialization
This patent provides broad coverage for pyrazole derivatives with kinase inhibitory activity. Its scope supports development of multiple candidates within this chemical space. Companies focusing on kinase inhibitors for cancer and inflammatory disease treatments should consider this patent in their freedom-to-operate analysis.
Key Takeaways
- The patent claims a broad class of substituted pyrazole compounds with therapeutic kinase inhibition activity.
- It covers chemical structures, synthesis methods, and medical uses.
- The patent landscape is competitive, with several related filings targeting similar compounds and indications.
- The patent expires in 2034, offering a window for commercialization.
- Thorough patent landscape analysis is required for R&D programs in this chemical space.
FAQs
1. Does the patent cover all pyrazole derivatives?
No, claims specify particular substitution patterns, limiting scope to compounds with defined structural features.
2. Are synthesis methods included in the claims?
Yes, specific methods of chemical synthesis are claimed, enabling production of the compounds.
3. What therapeutic areas are targeted?
Primarily kinase-related conditions, including cancers, inflammatory diseases, and possibly other proliferative disorders.
4. How does this patent compare to related patents?
It offers broader structural claims than some competitors but overlaps with other kinase inhibitor patents. Freedom-to-operate analysis is essential.
5. When will the patent expire?
It is set to expire in 2034, assuming maintenance fees are paid and no legal challenges arise.
References
[1] Patent and publication databases, USPTO, EPO, JPO.
[2] Patent landscape reports from Licensing Executives Society, 2020.
